AMEDEI, AMEDEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.460
EU - Europa 14.736
AS - Asia 11.171
SA - Sud America 1.367
Continente sconosciuto - Info sul continente non disponibili 635
AF - Africa 299
OC - Oceania 173
Totale 47.841
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.061
RU - Federazione Russa 4.254
IT - Italia 3.436
SG - Singapore 3.166
PL - Polonia 3.132
CN - Cina 2.894
HK - Hong Kong 1.681
BR - Brasile 1.082
VN - Vietnam 965
KR - Corea 950
IE - Irlanda 944
SE - Svezia 687
FI - Finlandia 536
FR - Francia 457
DE - Germania 395
IN - India 372
GB - Regno Unito 264
BD - Bangladesh 260
CA - Canada 250
ID - Indonesia 218
UA - Ucraina 183
AU - Australia 168
JO - Giordania 148
NL - Olanda 147
JP - Giappone 97
AR - Argentina 93
ES - Italia 77
TR - Turchia 67
IQ - Iraq 65
EC - Ecuador 64
MX - Messico 58
ZA - Sudafrica 52
CI - Costa d'Avorio 45
CH - Svizzera 44
NG - Nigeria 41
PK - Pakistan 35
EG - Egitto 34
AT - Austria 30
CO - Colombia 30
IR - Iran 29
BE - Belgio 27
CL - Cile 26
VE - Venezuela 26
MA - Marocco 25
SA - Arabia Saudita 23
PH - Filippine 22
CZ - Repubblica Ceca 20
UZ - Uzbekistan 20
BJ - Benin 19
MY - Malesia 19
PY - Paraguay 19
BB - Barbados 17
JM - Giamaica 17
KE - Kenya 17
LT - Lituania 17
DZ - Algeria 16
PE - Perù 16
TN - Tunisia 16
IL - Israele 15
KZ - Kazakistan 15
LB - Libano 15
CR - Costa Rica 14
RO - Romania 14
NP - Nepal 13
AE - Emirati Arabi Uniti 12
TH - Thailandia 11
TW - Taiwan 11
HN - Honduras 10
KG - Kirghizistan 10
SC - Seychelles 10
PT - Portogallo 9
AL - Albania 8
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
RS - Serbia 8
UY - Uruguay 8
OM - Oman 7
BG - Bulgaria 6
GR - Grecia 6
NI - Nicaragua 6
GT - Guatemala 5
NZ - Nuova Zelanda 5
UG - Uganda 5
BY - Bielorussia 4
DK - Danimarca 4
EE - Estonia 4
HR - Croazia 4
NO - Norvegia 4
SY - Repubblica araba siriana 4
BH - Bahrain 3
BO - Bolivia 3
ET - Etiopia 3
EU - Europa 3
HU - Ungheria 3
LV - Lettonia 3
MN - Mongolia 3
SN - Senegal 3
SV - El Salvador 3
YT - Mayotte 3
AM - Armenia 2
Totale 47.168
Salva come PNG Salva come JPEG
Città #
Santa Clara 3.597
Warsaw 3.123
Ashburn 2.785
Singapore 2.369
Fairfield 1.297
Hong Kong 1.262
Dublin 932
Seoul 926
Hefei 853
San Jose 720
Chandler 701
Seattle 566
Woodbridge 565
Milan 520
Cambridge 518
Houston 517
Beijing 447
Council Bluffs 426
Florence 417
Wilmington 417
Los Angeles 335
Altamura 315
Lawrence 309
Helsinki 289
Ho Chi Minh City 281
Rome 268
Jacksonville 256
Lauterbourg 256
Ann Arbor 243
Buffalo 228
Princeton 224
The Dalles 209
Hanoi 207
New York 202
Moscow 184
Dallas 178
Mumbai 177
Jakarta 162
Boston 161
Munich 147
Melbourne 141
Boardman 132
Kent 120
Shanghai 107
Chicago 104
Medford 102
São Paulo 93
Paris 91
Lappeenranta 88
Tokyo 88
San Diego 87
Dong Ket 86
Toronto 69
Bologna 68
Turin 65
London 62
Naples 60
Clifton 58
Orem 56
Atlanta 55
Frankfurt am Main 52
Guangzhou 49
Phoenix 48
Abidjan 45
Da Nang 45
Bengaluru 44
Brooklyn 43
Haiphong 41
Montreal 41
Redondo Beach 41
Turku 41
Pune 39
Abuja 38
Figino 37
Falls Church 36
Palermo 36
San Francisco 36
Miano 34
Hillsboro 33
Bari 32
Salt Lake City 32
Denver 29
Baghdad 28
Guayaquil 28
West Jordan 28
Chennai 27
Genoa 27
Yubileyny 26
Columbus 25
Amman 24
Rio de Janeiro 24
Vienna 23
Bern 22
Catania 22
Johannesburg 22
Tianjin 22
Amsterdam 21
Brussels 21
Norwalk 21
Venice 21
Totale 30.625
Salva come PNG Salva come JPEG
Nome #
Effects of the probiotic Lactiplantibacillus plantarum IMC 510® on body composition, biochemical parameters, gut microbiota composition and function, and clinical symptoms of overweight/obese subjects 744
H(+),K(+)-ATPase (proton pump) is the target autoantigen of Th1-type cytotoxic T cells in autoimmune gastritis. Gastroenterology 412
Preliminary comparison of oral and intestinal human microbiota in patients with colorectal cancer: a pilot study 402
Characterization of tumor antigen peptide-specific T cells isolated from the neoplastic tissue of patients with gastric adenocarcinoma. 359
Human 60 kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques. 350
Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. 343
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. 333
Tumor-associated macrophages as major source of APRIL in gastric MALT lymphoma. 309
Mucin Depleted Foci, Colonic Preneoplastic Lesions Lacking Muc2, Show Up-Regulation of Tlr2 but Not Bacterial Infiltration 307
Impaired T-cell regulation of B-cell growth in Helicobacter pylori--related gastric low-grade MALT lymphoma. 302
The Neutrophil Activating Protein of Helicobacter pylori promotes T helper type 1 immune responses. 300
Molecular mimicry between Helicobacter pylori antigens and H/K-ATPase in human gastric autoimmunity. 298
Circulating Calprotectin (cCLP) in autoimmune diseases 288
Intra-tumoral IFN-gamma-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer 286
T cells in gastric cancer: friends or foes. 274
The Trend of CEACAM3 Blood Expression as Number Index of the CTCs in the Colorectal Cancer Perioperative Course 274
Evaluation and comparison of short chain fatty acids composition in gut diseases 274
Healthy axis: Towards an integrated view of the gut-brain health 271
USE OF THE NEUTROPHIL ACTIVATING PROTEIN OF HELICOBACTER PYLORI (HP-NAP) AND/OR OF ITS PORTIONS AS ADJUVANTS FOR THE DEVELOPMENT OF T HELPER TYPE 1 (TH1) IMMUNE RESPONSES 270
Significant and Conflicting Correlation of IL-9 With Prevotella and Bacteroides in Human Colorectal Cancer 267
Visceral sensitivity modulation by faecal microbiota transplantation: the active role of gut bacteria in pain persistence 258
The different functional distribution of "not effector" T cells (Treg/Tnull) in colorectal cancer 257
T helper type-1 lymphocyte-drive inflammation in human atherosclerotic lesions. 256
Influence of a 3-month low-calorie Mediterranean diet compared to the vegetarian diet on human gut microbiota and SCFA: The CARDIVEG study 256
Potential Role of M. tuberculosis Specific IFN-γ and IL-2 ELISPOT Assays in Discriminating Children with Active or Latent Tuberculosis 251
I’ve gut a feeling: Microbiota impacting the conceptual and experimental perspectives of personalized medicine 248
Oral and fecal microbiota perturbance in cocaine users: Can rTMS-induced cocaine abstinence support eubiosis restoration? 243
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis 240
From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy. 238
The gut–brain axis in the neuropsychological disease model of obesity: A classical movie revised by the emerging director “microbiome” 234
Gastric cancer and the epoch of immunotherapy approaches 233
Effect of ancient Khorasan wheat on gut microbiota, inflammation, and short-chain fatty acid production in patients with fibromyalgia 232
Aflibercept plus folfiri as second-line treatment for metastatic colorectal cancer: A single-institution real-life experience 231
Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature 229
The increase of endothelial progenitor cells in the peripheral blood: a new parameter for detecting onset and severity of sepsis. 229
Treatment of colon cancer cells with 5-fluorouracil can improve the effectiveness of RNA-transfected antitumor dendritic cell vaccine 227
Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients 227
T cells and adoptive immunotherapy: recent developments and future prospects in gastrointestinal oncology. 227
Immunomodulating Activity and Therapeutic Effects of Short Chain Fatty Acids and Tryptophan Post-biotics in Inflammatory Bowel Disease 227
Chronic Systemic Low-Grade Inflammation and Modern Lifestyle: The Dark Role of Gut Microbiota on Related Diseases with a Focus on COVID-19 Pandemic 225
Role of Gut Microbiota-Immunity Axis in Patients Undergoing Surgery for Colorectal Cancer: Focus on Short and Long-Term Outcomes 224
Performance evaluation of four surrogate Virus Neutralization Tests (sVNTs) in comparison to the in vivo gold standard test 224
Inflammatory Bowel Disease and Customized Nutritional Intervention Focusing on Gut Microbiome Balance 223
Preliminary Analysis of the Presence of Bacterial Azurin Coding Gene in CRC Patients and Correlation with the Microbiota Composition 223
The lung microbiome: clinical and therapeutic implications 221
The Janus-Faced Role of Cell-Mediated Immune Responses in Pancreatic Cancer 220
Effect of probiotics on oral candidiasis: A systematic review and meta-analysis 218
A Machine Learning Decision Support System (DSS) for Neuroendocrine Tumor Patients Treated with Somatostatin Analog (SSA) Therapy 218
The link “Cancer and autoimmune diseases” in the light of microbiota: Evidence of a potential culprit 216
Thrombosis in vasculitis: from pathogenesis to treatment 213
The controversial role of Enterococcus faecalis in colorectal cancer 211
Broad targeting of angiogenesis for cancer prevention and therapy 210
Assessing T-Cell Immunity in Kidney Transplant Recipients with Absent Antibody Production after a 3rd Dose of the mRNA-1273 Vaccine 206
A new cytofluorimetric approach to evaluate the circulating microparticles in subjects with antiphospholipid antibodies 206
A Structurally Simple Vaccine Candidate Reduces Progression and Dissemination of Triple-Negative Breast Cancer 205
Breast cancer: the first comparative evaluation of oncobiome composition between males and females 203
A MULTI-DISEASE STATISTICAL ANALYSIS OF FREE FATTY ACID SIGNATURES ASSESSED BY GAS CHROMATOGRAPHY-MASS SPECTROMETRY 203
Association of systemic steroid treatment and outcome in patients treated with immune checkpoint inhibitors: A real-world analysis 203
Effect of ancient wheat pasta on gut microbiota composition and bacteria-derived metabolites: A randomized controlled trial 200
Circadian rhythms, gut microbiota, and diet: possible implications for health 199
Editorial of special issue “the interplay of microbiome and immune response in health and diseases” 198
Exploring the food-gut axis in immunotherapy response of cancer patients 198
Designing a broad-spectrum integrative approach for cancer prevention and treatment 198
Characterization of the "gut microbiota-immunity axis" and microbial lipid metabolites in atrophic and potential celiac disease 197
Vaginal lactobacilli and vaginal dysbiosis-associated bacteria differently affect cervical epithelial and immune homeostasis and anti-viral defenses 196
Broad targeting of resistance to apoptosis in cancer 195
The interplay between the microbiome and the adaptive immune response in cancer development 194
Characterization of H/K-ATPase T-cell epitopes in human autoimmune gastritis. 194
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets 194
Orchestration of inflammation and adaptive immunity in Borrelia burgdorferi-induced arthritis by neutrophil-activating protein A 193
Faecal microbiota transplant from aged donor mice affects spatial learning and memory via modulating hippocampal synaptic plasticity- and neurotransmission-related proteins in young recipients 193
Fecal metabolomic profiles: A comparative study of patients with colorectal cancer vs adenomatous polyps 193
Tissue invasion and metastasis: Molecular, biological and clinical perspectives 192
Identification of a posttranslational mechanism for the regulation of hERG1 K+ channel expression and hERG1 current density in tumor cells. 191
Hydrogen sulfide effects on the survival of lactobacilli with emphasis on the development of inflammatory bowel diseases 191
Effects of viremia and CD4 recovery on gut "microbiome-immunity" axis in treatment-naïve HIV-1-infected patients undergoing antiretroviral therapy 189
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: The challenge ahead 189
FETR-ALS Study Protocol: A Randomized Clinical Trial of Fecal Microbiota Transplantation in Amyotrophic Lateral Sclerosis 188
Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. 187
Chemotherapy resistance in acute lymphoblastic leukemia requires hERG1 channels and is overcome by hERG1 blockers. 187
Nicotinamide phosphoribosyltransferase (NAMPT) activity is essential for survival of resting lymphocytes 187
The differential crosstalk of the skin-gut microbiome axis as a new emerging actor in systemic sclerosis 186
Z-crystallin is a new stabilizing bcl-2 mRNA au-rich element binding protein overexpressed in the acute lymphocytic leukemia Jurkat T-CELL line 185
Gut microbiota and artificial intelligence approaches: A scoping review 184
Vav1 haploinsufficiency in a common variable immunodeficiency patient with defective T-cell function. 183
Peripheral ENO1-specific T cells mirror the intratumoral immune response and their presence is a potential prognostic factor for pancreatic adenocarcinoma 182
The role of neutralizing antibodies by sVNT after two doses of BNT162b2 mRNA vaccine in a cohort of Italian healthcare workers 182
Butyrate Rich Diets Improve Redox Status and Fibrin Lysis in Behçet's Syndrome 181
Role of diet and gut microbiota on Colorectal cancer immunomodulation 181
Oral microbiota signatures associated with viremia and CD4 recovery in treatment-naïve HIV-1-infected patients 180
Gut inflammatory diseases, infection, and nutrition 180
Beneficial Effects of Micronutrient Supplementation in Restoring the Altered Microbiota and Gut–Retina Axis in Patients with Neovascular Age-Related Macular Degeneration—A Randomized Clinical Trial 179
β2 Glycoprotein I Recognition Drives Th1 Inflammation in Atherosclerotic Plaques of Patients with Primary Antiphospholipid Syndrome 179
A multi-targeted approach to suppress tumor-promoting inflammation 178
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: Focus on the cancer hallmark of tumor angiogenesis 178
Free fatty acids signature in human intestinal disorders: Significant association between butyric acid and celiac disease 176
Editorial: Immune Checkpoint Molecules and Cancer Immunotherapy 175
Facial Skin Microbiome: Aging-Related Changes and Exploratory Functional Associations with Host Genetic Factors, a Pilot Study 174
Circulating miRNome profiling data in Behçet's syndrome 174
Evaluation of prognostic factors and clinicopathological patterns of recurrence after curative surgery for colorectal cancer 174
Totale 23.132
Salva come PNG Salva come JPEG
Categoria #
all - tutte 137.650
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 137.650
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.341 0 107 138 64 40 64 48 163 62 57 187 411
2022/20234.044 360 854 172 221 246 625 510 407 365 56 144 84
2023/20241.902 62 154 287 91 125 332 70 330 44 176 108 123
2024/202512.470 409 1.306 809 1.781 3.226 1.502 357 734 620 408 594 724
2025/202618.173 1.778 2.227 1.822 1.495 1.725 693 1.994 988 1.298 1.088 715 2.350
2026/20271.066 780 286 0 0 0 0 0 0 0 0 0 0
Totale 47.841